Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Free Cash Flow: -595.93M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -595.93M |
| June 30, 2023 | -591.23M |
| March 31, 2023 | -604.26M |
| December 31, 2022 | -575.42M |
| September 30, 2022 | -586.44M |
| June 30, 2022 | -496.44M |
| March 31, 2022 | -448.68M |
| December 31, 2021 | -398.60M |
| September 30, 2021 | -335.89M |
| June 30, 2021 | -365.05M |
| March 31, 2021 | -328.19M |
| December 31, 2020 | -275.90M |
| September 30, 2020 | -241.20M |
| June 30, 2020 | -196.03M |
| March 31, 2020 | -174.02M |
| December 31, 2019 | -149.28M |
| September 30, 2019 | -126.92M |
| June 30, 2019 | -114.11M |
| March 31, 2019 | -96.75M |
| December 31, 2018 | -70.22M |
| September 30, 2018 | -63.10M |
| June 30, 2018 | -57.99M |
| March 31, 2018 | -54.50M |
| December 31, 2017 | -64.79M |
| September 30, 2017 | -67.28M |
| Date | Value |
|---|---|
| June 30, 2017 | -70.50M |
| March 31, 2017 | -69.45M |
| December 31, 2016 | -68.21M |
| September 30, 2016 | -68.02M |
| June 30, 2016 | -65.57M |
| March 31, 2016 | -58.25M |
| December 31, 2015 | -51.04M |
| September 30, 2015 | -43.63M |
| June 30, 2015 | -37.44M |
| March 31, 2015 | -34.13M |
| December 31, 2014 | -33.13M |
| September 30, 2014 | -32.20M |
| June 30, 2014 | -27.76M |
| March 31, 2014 | -31.03M |
| December 31, 2013 | -29.66M |
| September 30, 2013 | -27.29M |
| June 30, 2013 | -26.25M |
| March 31, 2013 | -19.85M |
| December 31, 2012 | -16.88M |
| September 30, 2012 | -15.19M |
| June 30, 2012 | -13.44M |
| March 31, 2012 | -12.89M |
| December 31, 2011 | -11.43M |
| September 30, 2011 | -10.22M |
| June 30, 2011 | -12.08M |
Free Cash Flow Range, Past 5 Years
-604.26M
Minimum
Mar 2023
-114.11M
Maximum
Jun 2019
-366.87M
Average
-350.47M
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 12.51B |
| Karuna Therapeutics Inc (DELISTED) | -388.74M |
| Puma Biotechnology Inc | 35.61M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -143.71M |
| Cash from Investing (Quarterly) | -62.19M |
| Cash from Financing (Quarterly) | 334.70M |
| Free Cash Flow Per Share (Quarterly) | -2.212 |
| Free Cash Flow to Equity (Quarterly) | -143.75M |
| Free Cash Flow to Firm (Quarterly) | -143.75M |